opnurasib
novartis
['jdq443', 'valent ,(-prevalent),(-equivalent),(-bivalent)', 'valent ,(-prevalent)', 'novartis']
#aacr23: for more on beating #kras in - discovery, preclinical characterization and early clinical activity of jdq443, a structurally novel, potent and selective, covalent oral inhibitor of #krasg12c 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her